You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 19, May 16, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Iron Reduction and Cardiovascular Outcomes—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Sullivan and Katz identify key limitations of our study, including that it was a secondary prevention trial and that full iron reduction was not achieved. Trade-offs in clinical trial design, including the population selected for intervention, were recognized in planning. New insights on adherence and toxicity from our intent-to-treat analysis should enhance the design of more focused tests of the iron hypothesis in the future.

Dr Allison and colleagues are concerned that "conclusions of the post hoc analyses were misleading" because "age was not described in the initial study plan" and because subgroup analyses have limitations. They did not suggest how age effects should have been described, if at all.

We did not prejudge age effects in study design because our purpose was not to prove an interaction between age and iron reduction. Patients older than 21 years were eligible for entry, and age was a prespecified . . . [Full Text of this Article]

Leo R. Zacharski, MD
leo.r.zacharski@dartmouth.edu
Research Service
Department of Veterans Affairs Medical Center
White River Junction, Vt

Bruce K. Chow, MS
Research Service
Department of Veterans Affairs Medical Center
Palo Alto, Calif



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Iron Reduction and Cardiovascular Outcomes
Jerome L. Sullivan and Stuart D. Katz
JAMA. 2007;297(19):2075.
EXTRACT | FULL TEXT  

Iron Reduction and Cardiovascular Outcomes
Robert D. Allison, Barbara J. Bryant, Sumithira Vasu, and Susan F. Leitman
JAMA. 2007;297(19):2075-2076.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial
Leo R. Zacharski, Bruce K. Chow, Paula S. Howes, Galina Shamayeva, John A. Baron, Ronald L. Dalman, David J. Malenka, C. Keith Ozaki, and Philip W. Lavori
JAMA. 2007;297(6):603-610.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.